Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term mortality is increased in patients with undetected prediabetes and type-2 diabetes hospitalized for worsening heart failure and reduced ejection fraction.
Pavlović A, Polovina M, Ristić A, Seferović JP, Veljić I, Simeunović D, Milinković I, Krljanac G, Ašanin M, Oštrić-Pavlović I, Seferović PM. Pavlović A, et al. Among authors: asanin m. Eur J Prev Cardiol. 2019 Jan;26(1):72-82. doi: 10.1177/2047487318807767. Epub 2018 Oct 18. Eur J Prev Cardiol. 2019. PMID: 30335505
Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial.
Mrdovic I, Savic L, Krljanac G, Perunicic J, Asanin M, Lasica R, Antonijevic N, Kocev N, Marinkovic J, Vasiljevic Z, Ostojic M. Mrdovic I, et al. Among authors: asanin m. Coron Artery Dis. 2012 Jan;23(1):1-8. doi: 10.1097/MCA.0b013e32834df552. Coron Artery Dis. 2012. PMID: 22107800 Clinical Trial.
Impact of high post-loading platelet aggregation on 30-day clinical outcomes after primary percutaneous coronary intervention. The antiplatelet regimen tailoring after primary PCI (ART-PCI) trial.
Mrdovic I, Savic L, Krljanac G, Asanin M, Perunicic J, Antonijevic N, Lasica R, Marinkovic J, Kocev N, Vasiljevic Z. Mrdovic I, et al. Among authors: asanin m. Int J Cardiol. 2013 Aug 20;167(4):1632-7. doi: 10.1016/j.ijcard.2012.04.129. Epub 2012 May 22. Int J Cardiol. 2013. PMID: 22626838 Clinical Trial.
Usefulness of the RISK-PCI score to predict stent thrombosis in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a substudy of the RISK-PCI trial.
Mrdovic I, Savic L, Lasica R, Krljanac G, Asanin M, Brdar N, Djuricic N, Cvetinovic N, Marinkovic J, Perunicic J. Mrdovic I, et al. Among authors: asanin m. Heart Vessels. 2013 Jul;28(4):424-33. doi: 10.1007/s00380-012-0276-z. Epub 2012 Sep 14. Heart Vessels. 2013. PMID: 22975713
Rationale and design of the on-treatment PLAtelet Reactivity-Guided Therapy Modification FOR ST-Segment Elevation Myocardial Infarction (PLATFORM) randomized trial.
Mrdovic I, Savic L, Krljanac G, Asanin M, Cvetinovic N, Brdar N, Stojanovic M, Djuricic N, Stankovic S, Marinkovic J, Perunicic J. Mrdovic I, et al. Among authors: asanin m. J Interv Cardiol. 2013 Jun;26(3):221-7. doi: 10.1111/j.1540-8183.2013.12024.x. Epub 2013 Feb 4. J Interv Cardiol. 2013. PMID: 23373620 Free article. Clinical Trial.
137 results